Loading...
Keywords
Last Name
Institution
 Back to Details

Connection

Bradley Warady to Tissue Donors

This is a "connection" page, showing publications Bradley Warady has written about Tissue Donors.

 
Connection Strength
  
 
 
1.028
  
  1. Bryan CF, Winklhofer FT, Murillo D, Ross G, Nelson PW, Shield CF, Warady BA. Improving access to kidney transplantation without decreasing graft survival: long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients. Transplantation. 2005 Jul 15; 80(1):75-80.
    View in: PubMed
    Score: 0.269
  2. Bryan CF, Chadha V, Warady BA. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm. Pediatr Transplant. 2016 Nov; 20(7):926-930.
    View in: PubMed
    Score: 0.144
  3. Bryan CF, Aeder MI, Luger AM, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA. Incidence of a positive final antiglobulin (AHG) T-cell crossmatch in patients waiting for cadaveric renal transplantation is not influenced by race of recipient. Transplant Proc. 1993 Dec; 25(6):3273-4.
    View in: PubMed
    Score: 0.120
  4. Bryan CF, Tegtmeier GE, Rafik N, Markham LE, Murillo D, Nelson PW, Shield CF, Warady BA, Aeder MI. The risk for Chagas' disease in the Midwestern United States organ donor population is low. Clin Transplant. 2004; 18 Suppl 12:12-5.
    View in: PubMed
    Score: 0.061
  5. Muruve NA, Helling TS, Luger AM, Martinez J, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA, Aeder MI, Bryan CF. Effect of donor brain-death duration on graft outcome. Transplant Proc. 2001 Sep; 33(6):2980-1.
    View in: PubMed
    Score: 0.051
  6. Shen Q, Fang X, Man X, Zhai Y, Liu L, Wang C, Shang W, Feng G, Zhang L, Zeng L, Zhu Y, Chen J, Rao J, Warady BA, Schaefer F, Xu H. Pediatric kidney transplantation in China: an analysis from the IPNA Global Kidney Replacement Therapy Registry. Pediatr Nephrol. 2021 03; 36(3):685-692.
    View in: PubMed
    Score: 0.048
  7. Bryan CF, Shield CF, Warady BA, Aeder MI, Helling TS, Luger AM, Martinez J, Nelson PW, Pierce GE, Ross G, Muruve N, Thien ER. Influence of an historically positive crossmatch on cadaveric renal transplantation. Transplant Proc. 1999 Feb-Mar; 31(1-2):225-7.
    View in: PubMed
    Score: 0.043
  8. Bryan CF, Shield CF, Nelson PW, Pierce GE, Ross G, Luger AM, Warady BA, Helling TS, Aeder MI, Martinez J, Hughes TM, Beck ML, Harrell KM. Transplantation rate of the blood group B waiting list is increased by using A2 and A2B kidneys. Transplantation. 1998 Dec 27; 66(12):1714-7.
    View in: PubMed
    Score: 0.043
  9. Warady BA, Sullivan EK. Renal transplantation in children with sickle cell disease: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant. 1998 May; 2(2):130-3.
    View in: PubMed
    Score: 0.041
  10. Warady BA, H?bert D, Sullivan EK, Alexander SR, Tejani A. Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol. 1997 Feb; 11(1):49-64.
    View in: PubMed
    Score: 0.037
  11. Bryan CF, Tegtmeier GE, Polito A, Bayer W, Pierce GE, Shield CF, Warady BA, Aeder MI, Borkon AM, Estep TH, Forster J, Landreneau MD, Luger AM, Nelson PW, Ross G. Evaluation of the 3.0 Ortho EIA assay in 385 consecutive cadaveric organ donors. Transplant Proc. 1996 Feb; 28(1):155-6.
    View in: PubMed
    Score: 0.035
  12. Bryan CF, Shield CF, Warady BA, Aeder MI, Landreneau MD, Luger AM, Nelson PW, Pierce GE, Ross G. Allocation of kidneys to Afro-American patients is proportional to wait-list composition. Transplant Proc. 1996 Feb; 28(1):219-20.
    View in: PubMed
    Score: 0.035
  13. Bryan CF, Harrell K, Aeder MI, Luger AM, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA. Impact of HLA DR typing by polymerase chain reaction amplification with DR beta 1 sequence-specific primers on cadaveric renal allocation. Transplant Proc. 1993 Dec; 25(6):3060-3.
    View in: PubMed
    Score: 0.030
  14. Bryan CF, Wakefield M, Reese JC, Shield CF, Warady BA, Winklhofer FT, Murillo D. Renal graft survival is not influenced by a positive flow B-cell crossmatch. Clin Transplant. 2007 Jan-Feb; 21(1):72-9.
    View in: PubMed
    Score: 0.019
  15. Bryan CF, Nelson PW, Shield CF, Ross G, Warady B, Murillo D, Winklhofer FT. Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate. Clin Transpl. 2004; 127-33.
    View in: PubMed
    Score: 0.015
  16. Nelson PW, Shield CF, Muruve NA, Murillo D, Warady BA, Aeder MI, Bryan CF. Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: time for a new national system? Am J Transplant. 2002 Jan; 2(1):94-9.
    View in: PubMed
    Score: 0.013
  17. Bryan CF, Martinez J, Muruve N, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA, Aeder MI, Harrell KM, Helling TS, Luger AM. IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype. Clin Transplant. 2001; 15 Suppl 6:28-35.
    View in: PubMed
    Score: 0.012
  18. Bryan CF, Mitchell SI, Lin HM, Nelson PW, Shield CF, Luger AM, Pierce GE, Ross G, Warady BA, Aeder MI, Helling TS, Landreneau MD, Harrell KM. Influence of the Rh (D) blood group system on graft survival in renal transplantation. Transplantation. 1998 Feb 27; 65(4):588-92.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.